Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
LifeMD Inc has a consensus price target of $12.13 based on the ratings of 8 analysts. The high is $15 issued by Cantor Fitzgerald on September 20, 2024. The low is $7 issued by Mizuho on December 4, 2024. The 3 most-recent analyst ratings were released by Lake Street, Mizuho, and HC Wainwright & Co. on December 10, 2024, December 4, 2024, and November 11, 2024, respectively. With an average price target of $10.33 between Lake Street, Mizuho, and HC Wainwright & Co., there's an implied 99.49% upside for LifeMD Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for LifeMD (NASDAQ:LFMD) was reported by Lake Street on December 10, 2024. The analyst firm set a price target for $12.00 expecting LFMD to rise to within 12 months (a possible 131.66% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for LifeMD (NASDAQ:LFMD) was provided by Lake Street, and LifeMD initiated their buy rating.
There is no last upgrade for LifeMD
There is no last downgrade for LifeMD.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeMD was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.
While ratings are subjective and will change, the latest LifeMD (LFMD) rating was a initiated with a price target of $0.00 to $12.00. The current price LifeMD (LFMD) is trading at is $5.18, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.